Stage IIIA Breast Cancer Completed Phase 3 Trials for Epirubicin (DB00445)

IndicationStatusPhase
DBCOND0028774 (Stage IIIA Breast Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00513292Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by SurgeryTreatment